Variation in beta-alpha synthesis ratios in thalassemia and hemoglobinopathies.
D000744:Anemia, Hemolytic, Autoimmune / Q000378:metabolism; D000755:Anemia, Sickle Cell / Q000378:metabolism; D001853:Bone Marrow / Q000378:metabolism; D001854:Bone Marrow Cells; D002250:Carbon Radioisotopes; D004905:Erythrocyte Aging; D004912:Erythrocytes / Q000378:metabolism; D005914:Globins / Q000096:biosynthesis; D006445:Hemoglobin C Disease / Q000378:metabolism; D006453:Hemoglobinopathies / Q000378:metabolism*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007930:Leucine / Q000378:metabolism; D010443:Peptide Chain Termination, Translational; D010446:Peptide Fragments / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000378:metabolism; D013789:Thalassemia / Q000235:genetics / Q000378:metabolism*; D014316:Tritium; D014357:Trypsin / Q000494:pharmacology; D014633:Valine / Q000378:metabolism
D002250:Carbon Radioisotopes; D010446:Peptide Fragments; D012333:RNA, Messenger; D014316:Tritium; D005914:Globins; D014357:Trypsin; D007930:Leucine; D014633:Valine